Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Open-label Study Evaluating The Safety And Efficacy of Anti CD19/22 CAR-T Cells Therapy Adults With R/ R Leukemia/ Lymphoma

NCT07162571 is registered in ClinicalTrials.gov with Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology as lead sponsor.

NCT NCT07162571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07162571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Open-label Study Evaluating The Safety And Efficacy of Anti CD19/22 CAR-T Cells Therapy Adults With R/ R Leukemia/ Lymphoma
Lead sponsor
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
December 31, 2031
Enrollment
17 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphobkastic leukemia, b cell lymphoma